Member Info for Bazzaman

Let's hope the 🤡 is a better communicator in September as August was $hite with a single RNS the standard of which was woeful. Vote him out!!

Monday week will be the 8th September, 5 months since the Amsterdam launch. Anybody expecting to hear anything from the 🤡 by then? Thought not, still hiding in his bunker awaiting more Royalties from Croda so he can mask the poor performance of his acquisitions.

3 more months before we can vote him out, don't miss this opportunity.

GLA

It's clear they are trying every trick in the book to get hold of shares ahead of the ASX 200 listing come September. They are not getting any of mine.

One thing for certain is that when the 🤡 does decide to communicate, you have to take what he says with a pinch of salt.

Zenakine might but that is offset by the 🤡

Nobody knows what's going on with all the trades over the last couple of months, no TR1's and total silence from the 🤡 doesn't help.

Should have said '£950k over 3 years charged at 13% interest, first 2 years quarterly interest and year 3 quarterly payments of capital and interest.

BTS acquisition was in October 2024 with Ashman drooling over all the opportunities/synergies it would bring including 24 hour processing. As anybody heard anything about any improvements he has made, thought not yet more empty promises. Looking back at the terms of the acquisition, being funded by a loan of £950,000 with an existing shareholder (DB) and a subscription for 2,349,624 new Ordinary Shares at 10.64p raising £250,000, as well as utilisation of Group cash reserves. £950k over 3 years charged at 13% interest first 2 years quarterly interest and year 3 quarterly and interest. In addition, the Company has entered into a subscription agreement with the same investor to subscribe for 2,349,624 new Ordinary Shares at 10.64p raising £250,000. Ashman said at the time "I'd like to thank David Brierwood for his help in completing this deal. He has been a long-term supporter of both SkinBioTherapeutics and our strategy to transform the Group through acquisitions of complementary businesses." DB said "I have long admired SkinBioTherapeutics' ambitions to transform the skin healthcare market, and have watched with increasing conviction as the business model has evolved over the past few years. I am delighted to have been able to support the Group to achieve this next milestone acquisition and enabling the transformation of SkinBioTherapeutics from an R&D company to a revenue-generating, profitable commercial Group."

And then comes along Superdrug;

In order to provide additional working capital to facilitate and support the Commercial Agreement and future formulation and packaging requirements, the Company has today raised £4.1m (gross) via a placing (the "Placing") and a subscription (the "Subscription") of 24,117,645 new ordinary shares of 1p (the "New Ordinary Shares") at 17 pence each (the "Issue Price"). The Issue Price represents no discount to the Company's closing bid-price on 13 June 2025 (being the last practicable day prior to the publication of this Announcement). The Placing is being made available to certain institutional investors, including Premier Miton. Under the terms of the Subscription David Brierwood (who currently holds 5.51% of the Company's ordinary shares) has subscribed for a total of £600,000 which equates to 3,529,411 New Ordinary Shares as part of the fundraising, at the Issue Price and at the same time as the Placing.

So without DB, Ashman would already be history sunk without trace.

Ashman has had his day, overpaid, overrated, clueless & useless. Bye, bye.

Ashman's a clown. Even his (very) few supporters that are left seem to have given up posting anything positive to say about him or the company. September is likely to focus on Superdrug launch but with hardly any detail. Nothing on Croda until December and even then no details on royalty revenues. NDA will last until 2027 if SBTX survives independently until then. No wonder every day the SP sales get larger and more of them. Confidence is Ashman is probably worst than confidence in Starmer and that's saying something.

Ashman has zero interest in buying SBTX shares, no excuse as Croda directors continue to buy their company shares. His has no communication skills, all of the RNS's are some of the worst ever published on AIM.

Don't forget come the AGM vote him out along with the useless Chairman as well.

GLA, we are going to need it.

Is not us

Looks like the selling is intensifying whilst the clown snoozes in his bunker, oblivious to what us going on.

PG I don't agree, It's just another made up excuse for Ashman to hide behind exactly like the NDA. Let's face it, he is a poor CEO who isn't aligned with us shareholders.

But so are Croda directors.

I see Croda directors are still buying their shares. What is Ashman's excuse?

An interesting update from Alex has just surfaced. His buy today is showing as a sell, no surprise there. They seem to continue to support the clown and suggest all will come good for FY2026. Let's hope they are right.

Bank holiday here on Monday but not in Australia so extra trading them for them.

Ashman stated these two things in his TU;

1. Post year end, July was a strong month with significant orders and good trading across the board, especially for the BTS business.

2. The Company will be reporting its full year results later in the year and will hold a presentation for shareholders at that time. In the meantime, it will report any material information and information of potential interest to shareholders via the RNS system.

So was July performance material or not? If it was then where is the RNS?

He promises so much and delivers so little.

Aquae, you don't know how the cash figure is made up. £4.8m includes placing (known) plus Croda revenue (unknown) minus spend on Superdrug (stated but who knows what to believe). Sounds to me like they needed some of the placing cash as ongoing WC.

It's all guesswork and we won't know until the audited results come out in December.

Recommended in Shares magazine today as well.